ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Hypothesis   
  • Clin Pharmacol Biopharm,

Biomarkers in Precision Medicine: Advancements in Diagnosis, Prognosis and Treatment Monitoring

Muhammad Alsanie*
Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Pakistan
*Corresponding Author : Muhammad Alsanie, Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Pakistan, Email: muhammadalsanie8989@gmail.com

Received Date: Oct 03, 2024 / Published Date: Oct 30, 2024

Abstract

Biomarkers are integral to the evolution of precision medicine, serving as key indicators for diagnosis, prognosis, and treatment monitoring across various diseases. This review examines the latest advancements in biomarker research and their applications in enhancing precision medicine. We explore how biomarkers facilitate early disease detection, enabling timely interventions that improve patient outcomes. Furthermore, we discuss the role of prognostic biomarkers in predicting disease progression and treatment response, allowing for tailored therapeutic approaches. Advances in technology, such as genomics, proteomics, and liquid biopsies, have significantly expanded the repertoire of actionable biomarkers, leading to more personalized treatment strategies. Additionally, we address the challenges of biomarker validation and implementation in clinical practice and highlight future directions for research aimed at optimizing the use of biomarkers in patient management. This comprehensive overview underscores the transformative potential of biomarkers in revolutionizing the landscape of precision medicine, ultimately leading to improved healthcare outcomes.

Citation: Muhammad A (2024) Biomarkers in Precision Medicine: Advancementsin Diagnosis, Prognosis and Treatment Monitoring Clin Pharmacol Biopharm, 13:499.

Copyright: © 2024 Muhammad A. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top